Relevant bibliographies by topics / Supportive medicines in cancer

Academic literature on the topic 'Supportive medicines in cancer'

Author: Grafiati
Published: 10 December 2022
Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Supportive medicines in cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Supportive medicines in cancer"

1

Gurney, Jason K., James Stanley, Jonathan Adler, Heather McLeod, June Atkinson, and Diana Sarfati. "National Study of Pain Medicine Access Among Māori and Non-Māori Patients With Lung Cancer in New Zealand." JCO Global Oncology, no. 7 (August 2021): 1276–85. http://dx.doi.org/10.1200/go.21.00141.

Full text
Abstract:
PURPOSE Pain is among the most common and consequential symptoms of cancer, particularly in the context of lung cancer. Māori have extremely high rates of lung cancer, and there is evidence that Māori patients with lung cancer are less likely to receive curative treatment and more likely to receive palliative treatment and to wait longer for their treatment than non-Māori New Zealanders. The extent to which Māori patients with lung cancer are also less likely to have access to pain medicines as part of their supportive care remains unclear. METHODS Using national-level Cancer Registry and linked health records, we describe access to subsidized pain medicines among patients with lung cancer diagnosed over the decade spanning 2007-2016 and compare access between Māori and non-Māori patients. Descriptive and logistic regression methods were used to compare access between ethnic groups. RESULTS We observed that the majority of patients with lung cancer are accessing some form of pain medicine and there do not appear to be strong differences between Māori and non-Māori in terms of overall access or the type of pain medicine dispensed. However, Māori patients appeared more likely than non-Māori to first access pain medicines within 2 weeks before their death and commensurately less likely to access them more than 24 weeks before death. CONCLUSION Given the plausibility that there are differences in first access to pain medicines (particularly opioid medicines) among Māori approaching end of life, further investigation of the factors contributing to this disparity is required.
APA, Harvard, Vancouver, ISO, and other styles
2

Motoo, Yoshiharu, and Silke Cameron. "Kampo medicines for supportive care of patients with cancer: A brief review." Integrative Medicine Research 11, no. 2 (June 2022): 100839. http://dx.doi.org/10.1016/j.imr.2022.100839.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kelly, Kara M. "Complementary and alternative medicines for use in supportive care in pediatric cancer." Supportive Care in Cancer 15, no. 4 (October 12, 2006): 457–60. http://dx.doi.org/10.1007/s00520-006-0162-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Unguru, Yoram, Melanie Brooke Bernhardt, Stacey L. Berg, Liza-Marie Johnson, Kimberly Pyke-Grimm, Catherine Woodman, and Conrad V. Fernandez. "Chemotherapy and Supportive Care Agents as Essential Medicines for Children With Cancer." JAMA Pediatrics 173, no. 5 (May 1, 2019): 477. http://dx.doi.org/10.1001/jamapediatrics.2019.0070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lee, R., and J. Von Roenn. "Is best supportive care really best supportive care?" Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 9639. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.9639.

Full text
Abstract:
9639 Background: With the growth of palliative medicine over the past decade, the paradigm of supportive care has evolved to create new standards for cancer patients. The aim of this study was to define “best supportive care” (BSC) during clinical trials of advanced solid tumors. Methods: Systematic review of the literature using Medline and the Cochrane Central Register of Controlled Trials databases. These were searched for randomized controlled trials in which anticancer therapy was compared with a BSC only arm. Results: A total of 43 studies met our inclusion criteria (publication dates, 1980–2008) with the following cancer types: 22 lung cancer, 6 colorectal, 6 pancreas, 2 gastric, and 7 other cancer types. Thirty-eight studies (88%) provided some definition of supportive care and sixteen studies (37%) used the term BSC. The average survival across treatment arms was 27.5 weeks. All but one study described the use of palliative therapies at the discretion of the treating physician without standardization. Over half of all studies (56%) specifically mentioned analgesics and radiotherapy (RT) for pain control. Other specific interventions listed were steroids (14), antibiotics (10), psychological support (10), nutritional support (9), blood transfusions (8), anti-emetics (6), and anti-depressant or anxiolytic medications (3). One-third of trials (15) reported an equivalent clinical evaluation schedule for both the BSC and treatment arms. Quality of life (QoL) was measured with a validated instrument (e.g., QLQ-30) in 55% of trials and 37% compared the utilization of at least one palliative treatment between groups. Trials using the term BSC were more likely to provide multidisciplinary therapy beyond RT and analgesics (50% vs. 19%; p<0.05). Conclusions: The management of subjects in a BSC arm of clinical trials are highly variable. Overall, the trials compare treatment versus no treatment as subjects in the BSC group likely did not receive care according to current palliative medicine standards. Future randomized clinical trials with a BSC arm should provide a comprehensive, multidisciplinary approach that is consistent with practice guidelines. A standardized BSC approach developed with palliative medicine specialists is warranted for further study. No significant financial relationships to disclose.
APA, Harvard, Vancouver, ISO, and other styles
6

Cassileth, BR, and K. Simon Yeung. "Supportive Cancer Care with Chinese Medicine." Focus on Alternative and Complementary Therapies 15, no. 3 (August 31, 2010): 261–62. http://dx.doi.org/10.1111/j.2042-7166.2010.01039.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sagar, Stephen M., and Raimond Wong. "Chinese medicine and supportive cancer care." Evidence-Based Integrative Medicine 1, no. 1 (2003): 11–25. http://dx.doi.org/10.2165/01197065-200301010-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Escudero, A., M. Mejia, L. Martínez, C. Martí, G. Marcos, and D. Barreda. "PS-059 Serious medicines errors related to antineoplasic and supportive treatment in cancer patients." European Journal of Hospital Pharmacy 21, Suppl 1 (February 24, 2014): A167.3—A168. http://dx.doi.org/10.1136/ejhpharm-2013-000436.410.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gourret Baumgart, Jade, Hélène Kane, Sylvie Pelletier, Karine André, Catherine Barbe, Thierry Lecomte, Yacine Sam, Nizar Messai, Emmanuel Rusch, and Frédéric Denis. "Understanding Inequalities in the Uptake of Supportive Care to Improve Practices in the Cancer Care Continuum." Cancers 14, no. 24 (December 8, 2022): 6053. http://dx.doi.org/10.3390/cancers14246053.

Full text
Abstract:
(1) Background: While inequalities in the prevalence of cancer, access to care, and survival have been well documented, less research has focused on inequalities in the uptake of supportive oncology care. Given its contribution to improving the quality of life of people affected by cancer, access to such care is a major public health issue. The present study focuses on the access and uptake of those supportive oncology care services. (2) Methods: This study is based on qualitative research methodology, using a thematic analysis tree on NVivo© analysis software. First, an exploratory survey was conducted with users of oncology services, and professionals from these services and supportive oncology care. Then, individual interviews were conducted in June 2022 among people who are currently being treated or have been treated for cancer. (3) Results: The experiences of the 33 respondents revealed that significant variations in the uptake of supportive oncology care are underpinned by identifiable disparities in their healthcare pathways: in their assimilation of information, difficulties in accessing oncology care, personal reluctance and motivations, perceived needs and benefits, and use of other medicines. (4) Conclusion: This study aims to gain some insight into disparities in the uptake of supportive care in the Centre-Val de Loire region (France). Thus, it provides a better understanding of the complex ways in which these inequalities in supportive oncology care uptake are constructed.
APA, Harvard, Vancouver, ISO, and other styles
10

Sonis, Stephen T. "Genomics, Personalized Medicine, and Supportive Cancer Care." American Society of Clinical Oncology Educational Book, no. 35 (May 2015): 9–16. http://dx.doi.org/10.14694/edbook_am.2015.35.9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Supportive medicines in cancer"

1

du, Plessis Johannes. "Family experiences and viewpoints of palliative and supportive care for children with cancer: Can we do better?" Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/25066.

Full text
Abstract:
Background: The palliative and supportive care needs of children with cancer and their families are unique and require special attention. Children and their families in Africa facing lifethreatening/ life-limiting diseases have unique needs and have the right to achieve effective and evidence-based care. Development of appropriate services sensitive to the needs of families and based on observed evidence has become more and more recognized. As an introduction to develop and improve supportive and palliative care services for children with cancer, families were questioned regarding their experiences and suggestions for improvements. Methods: Sixteen family members of children with cancer and treated at Universitas Academic Hospital, Bloemfontein, South Africa, were questioned regarding their children's standard oncology and supportive/palliative care. Their responses were studied and repeating themes were identified. Results: A number of areas of need were identified: erratic psychosocial support, minimal financial support, poor parental access to basic needs and food provision, preventable errors in procedures and lack of sibling support. Staff were also not always sufficiently equipped to attend to palliative care patients. Conclusions: Supportive and palliative care for children with cancer needs to be improved. Family members are a valuable resource and the interviews identified a number of themes, valuable to consider in the expansion of a supportive/palliative care service. The intension of the study was to create the awareness that by making small and affordable changes, the quality of care that children and families receive can be improved.
APA, Harvard, Vancouver, ISO, and other styles
2

Farley, Amanda Claire. "Health and supportive care needs of surgical lung cancer patients, and the prognostic significance of smoking." Thesis, University of Birmingham, 2014. http://etheses.bham.ac.uk//id/eprint/4979/.

Full text
Abstract:
Aims: This thesis investigated the health and supportive care needs of surgical lung cancer patients to address gaps in the evidence base and inform future service developments. Additionally, the prognostic significance of smoking behaviour was investigated. Methods: Semi-structured interviews were conducted with 29 surgical (VATS and thoracotomy) lung cancer patients to explore health, functioning, smoking, satisfaction with recovery and preferences for a tailored rehabilitation programme. Interviews were analysed using framework approach. Systematic literature searches were conducted to review evidence of the association between smoking history or continued smoking after diagnosis and prognosis. Survival estimates were combined where possible using a random effect inverse variance model. Results: Most participants experienced difficulty during recovery. Breathlessness and pain emerged as dominant health challenges. Participants were open to being offered smoking cessation support. From 78 and 10 studies, preliminary evidence was found that both smoking history and continued smoking are associated with prognosis, respectively. Analyses indicated that smoking-associated increased risk may be mediated through cancer-related pathways. Conclusions: Many surgical lung cancer patients’ supportive care needs are not being met. Well-developed treatments and services for management of breathlessness, pain and smoking cessation may improve quality of life and health outcomes after lung cancer surgery, and require further testing.
APA, Harvard, Vancouver, ISO, and other styles
3

Wong, Margurite Elvina. "Supporting Chinese-speaking cancer patients to make safe and informed complementary medicine decicions." Thesis, University of British Columbia, 2012. http://hdl.handle.net/2429/42129.

Full text
Abstract:
Clinical observation indicated that there were a substantial number of Chinese-speaking cancer patients receiving care at the British Columbia Cancer Agency (BCCA) located in Vancouver, where the second largest Chinese Canadian population resides. CAM has been popular among Chinese-speaking cancer patients around the world, but little research has been done to examine the prevalence of CAM use in these patients in Canada. It was found that almost half of these patients used CAM and their preferred choice of CAM therapy was biological-based therapy that included natural health products (NHPs) and traditional Chinese medicine (TCM). The use of CAM is controversial because of its potential to interact with conventional cancer treatment and other medications. Due to a lack of culturally relevant CAM information and decision support intervention, many Chinese-speaking patients were using CAM without adequate support. This type of support is urgently needed to help these patients to make safe and informed CAM decisions. Knowledge about their CAM decision-making experiences and the types of CAM information and decision supports needs are required to create such interventions. A sequential multi-method research design was used for this study, which occurred in two phases: a quantitative secondary data analysis and qualitative semi-structured interviews. In this study, we found that more than 65% of the Chinese-speaking cancer patients surveyed reported to have used CAM since their diagnoses, and the prevalence of its use was significantly higher than that used by the mainstream cancer population. There were two types of CAM decision-making experience: Spontaneous and deliberate. The spontaneous decision makers relied heavily on their peers to help with decision making, whereas the deliberate decision makers gathered information from multiple sources and selected the CAM therapies that were safe and fitted their cultural health beliefs and their previous CAM use experience. In addition, the group of patients also had unique CAM information and decisions supports needs. All this newly gained knowledge would contribute to the development of future interventions to help theses patients to make safe and informed CAM decisions.
APA, Harvard, Vancouver, ISO, and other styles
4

Salas-Vega, Sebastian. "Cancer medicines : clinical impact, economics, and value." Thesis, London School of Economics and Political Science (University of London), 2017. http://etheses.lse.ac.uk/3647/.

Full text
Abstract:
Background and Importance: There has been much debate recently over rapidly growing drug expenditures. Cancer medicines, in particular, have driven new brand spending over recent years, and US oncological expenditures have risen faster than for many other disease areas, in part because of rapidly growing drug prices, as well as increased rates of use. Objective: In the face of ongoing debates on how to reasonably control growth in pharmaceutical spending, while also providing patients with the best possible care, this thesis sets out to help address the question of whether growing pharmaceutical expenditures are providing value-for-money to patients and society. Novelty and Empirical Contributions: This thesis is based in part on a systematic review with narrative synthesis of English-language HTA appraisals of the comparative clinical risks and benefits of new cancer medicines, as well as on the novel use of methods to generate comparative evidence on their use and cost. Adapting established methods, these data are then used to examine existing questions over whether growing expenditures are worth the cost to patients and society. This thesis makes five major contributions to the literature on value-based spending on cancer medicines: 1) approximately one in three newly licensed cancer medicines provide no known overall survival benefit, while one in five provide no known overall survival, quality of life, or safety benefit; 2) novel use of methodologies to model treatment course and duration reveals that cancer drug use and costs vary greatly between individual medicines, and across Australia, France, the UK, and the US; 3) the monetized value of survival gains attributable to cancer drug innovation, net of growth in cancer drug spending, varies across individual medicines, and, at a country-level, remains unambiguously positive in Australia, France, and the UK, but negative in the US; 4) spending on new cancer medicines is often only weakly associated with their clinical benefits; and 5) the strength of this association nevertheless varies across countries, with the UK demonstrating the strongest evidence of value-based spending on new cancer medicines. Clinical and Policy Implications: Findings from this thesis provide a resource for valuebased clinical decision-making by patients and physicians. Moreover, growing expenditures on cancer medicines may only weakly be associated with meaningful clinical benefits, though the extent to which this is true differs across countries. These findings highlight the important role that health policy can have in encouraging valuebased cancer drug spending. In particular, it is argued that managed access schemes promoting access and evidence development, as well as the use of value-based spending policies, can help expedite access to new treatments, incentivize the development of clinically meaningful medicines, and rationalize growing cancer drug expenditures. Future Research Directions: The comparative clinical risks and benefits from new cancer medicines using real-world data, and how they compare with trial-based results; how evidence on the comparative impact from new treatments is measured, weighted, and rewarded in decision-making by regulators and payers; and how it is effectively linked through policy and regulation to cancer drug spending.
APA, Harvard, Vancouver, ISO, and other styles
5

譚郭雅欣 and Gloria Tam. "Non-small cell lung cancer clinical trials on new medicines." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41711956.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Fang, Rui. "Investigation of some traditional Chinese medicines used to treat cancer." Thesis, King's College London (University of London), 2006. https://kclpure.kcl.ac.uk/portal/en/theses/investigation-of-some-traditional-chinese-medicines-used-to-treat-cancer(c889892f-19cd-4a7a-908c-faaeec106eb7).html.

Full text
Abstract:
The aim of the present project is to study five Traditional Chinese Medicines (TCM) used traditionally in China for the treatment of cancer. They are Dolichos lablab L., Gekko swinhonis Gunther, Illicium verum Hook. f, Lonicera japonica Thunb. and Iris tectorum Maxim. Solvent extractions of the TCMs were subjected to bioassay-guided fractionation and isolation, yielding series of fractions with increasing purity and cytotoxicity. The cytotoxicity assay used comprised four human cancer cell lines (COR-L23, C32, MCF-7 and HepG2) and two human normal cell lines (MRC-5 and 16HBE14o-). The separation of organic components was carried out mainly by means of TLC, VLC and HPLC. Isolation and purification of bioactive compounds from the active extract of I. tectorum, the most potent source tested, led to the identification of two known flavonoids (tectorigenin and 7-0-methyl-aromadendrin), two known triterpenes (isoiridogermanal and iridobelamal A) and two novel triterpenes. The structures of the latter were determined by mass spectrometry and infrared and 2D nuclear magnetic resonance spectroscopic techniques. Induction of apoptosis by the isolated compounds was investigated using flow cytometry with quadrant analysis, and confirmed by fluorescence microscopy. Furthermore, cell cycle specific cytotoxicity was determined by DNA analysis. The selectivity of cytotoxicity activity, modes of action and structure-activity relationships of the compounds are discussed. Also, a cell culture-based prodrug assay was established for high-throughput screening of potential glucosides, which are inactive in vitro but may be metabolized to active aglycones in vivo. In summary. the results obtained showed that selection based on ethnopharmacology, together with a robust and reliable method to detect biological activity, can be a useful approach for exploring traditional medicines for novel cytotoxic substances.
APA, Harvard, Vancouver, ISO, and other styles
7

Tam, Gloria. "Non-small cell lung cancer clinical trials on new medicines." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B41711956.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Beesley, Vanessa Lea. "The experience of gynaecological cancer survivors : supportive care needs and use." Thesis, Queensland University of Technology, 2006. https://eprints.qut.edu.au/16355/1/Vanessa_Beesley_Thesis.pdf.

Full text
Abstract:
Gynaecological cancer survivorship has been addressed in only a limited body of research. After completion of treatment, women with gynaecological cancer face many challenges. It is pertinent that we understand the wellbeing and morbidity issues of this group of survivors, as well as their supportive care needs and use. With this understanding, it will be possible to better target health care initiatives and services to those gynaecological cancer survivors who require help. Accordingly, the objectives of this study were to determine the prevalence of site-specific morbidities, support being utilised, and unmet needs, as well as to determine the correlates of supportive care needs and use. To address this, a cross-sectional mail survey of 1774 Queensland gynaecological cancer survivors three months to five years post-diagnosis was conducted in 2004 (56.5% response rate, n=802 of 1420 eligible participants). Women were recruited from the Queensland Gynaecological Cancer Registry, which covered approximately 85% of all gynaecological cancer patients in Queensland at the time of this study. The questionnaire measured a range of factors to reflect a social-ecological perspective. This broader perspective was utilised to extend the current understanding which is limited to a biopsychosocial approach. Main outcomes were measured with standardised and validated instruments where possible, including the Supportive Care Needs Survey, Functional Assessment of Cancer Therapy, Duke-UNC Functional Social Support Questionnaire and the Active Australia Survey. The results of this survey showed that while quality of life was high on average (median 91, range 30-108), some women experienced debilitating site-specific conditions. Ten percent reported being diagnosed with lower limb lymphoedema and eight percent of women reported that their gynaecological cancer had made sexual relations too difficult or too uncomfortable. Women accessed multiple sources of support within their communities including a variety of support services (54%) and complementary therapies (29%). Characteristics associated with use of support services include: younger age, being retired, having been diagnosed with a gynaecological cancer other than uterine, having had open bowel resection, having been treated at multiple centres, being in remission, being obese. On average, women reported having excellent social support (median 37, range 8-40). Some women made changes to healthier behaviours following their cancer diagnosis, such as increasing their fruit and vegetable intake (23%) or physical activity levels (10%) or decreasing their alcohol consumption (24%) or cigarette smoking (10%); however, nearly half (44%) of women decreased their physical activity level. A population comparison of health behaviours between gynaecological cancer survivors and Queensland women highlighted the significantly lower level of sufficient physical activity and higher level of obesity in the cancer survivor population, as well as the low levels of adequate vegetable intake in both populations. Forty-three percent of gynaecological cancer survivors reported having at least one moderate or high level unmet supportive care need. In particular, needing help with fear about the cancer spreading, concerns about the worries of those close to them, uncertainty about the future, lack of energy/tiredness, and not being able to do things they used to do, were most important to this group. These leading need items were all within the psychological and physical/daily living supportive care domains. Some unmet sexuality and health system/information needs were also reported. Groups with higher odds of unmet needs included those women who more recently completed treatment, whose disease was still present, who had children still living in the home, who had diagnosed lymphoedema, who experienced treatment-related menopause, who were unable to work due to illness and who lived in rural and remote regions of Queensland. These results indicate that women with gynaecological cancer in Queensland are doing quite well overall; however, there is still room for improvement in a few key areas of public health importance. In line with the social-ecological model, resources need to be targeted at all levels of support including personal, social, health care and broader organisational, community, policy and media levels. In particular, the following recommendations are made: 1. Assistance with the particular reported unmet psychological and physical/daily living needs is a priority. Support services should be tailored to the identified groups of survivors who had higher odds of unmet needs, both in terms of development of written materials that reflect these groups' circumstances and implementation of programs or workshops specific to these groups. In particular, the development of a number of programs or workshops are recommended that discuss the specific psychological and physical/ daily living outcomes of women who a) live with cancer, b) live with children after cancer treatment, c) live with lymphoedema, d) have had treatment-related menopause or e) are unable to work due to illness, and how and where women can get help with managing these. These programs should be implemented by support organisations in the period closely following treatment completion and should consider technologies such as video-conferencing to reach women who are in rural and remote areas. 2. More specific written information for cancer survivors about things they can do to help themselves get well is needed, in lay-person friendly format. This information should address the value of particular dietary items, complementary therapies and types of physical activities that are safe and beneficial to cancer survivors' quality of life. 3. An evidenced-based physical activity intervention, targeting overweight and obese gynaecological cancer survivors is recommended, to reduce the weight issues of this population. 4. To facilitate the triage of cancer survivors to appropriate health care information and other support initiatives, cancer survivors' awareness of the Queensland Cancer Fund needs to be raised substantially. Practitioner education and discharge planning directives are recommended to ensure information about the Queensland Cancer Fund is disseminated. 5. To address the substantially unmet information and physical/ daily living needs specific to lymphoedema sufferers, it is recommended that self-management information and referral information for suppliers and services for lymphoedema management be given to women in high lymphoedema risk groups, as part of the hospital discharge procedure, as well as when symptoms are diagnosed, to ensure a continuum of care is maintained. 6. Clinical practice guidelines for cancer care and, correspondingly, support programs, need to expand from acute care to managing the long-term psychological, physical and sexual health consequences. Several topics for research are likely to be important in the future, including more specific research into why uterine cancer survivors reported higher odds of unmet psychological needs and yet were less likely to use support services, what specific help women with unmet needs would prefer, the effects of lower limb lymphoedema on survivors' quality of life, and why there isn't greater use of existing support services, especially among women with morbidity such as lymphoedema and issues associated with treatment-related menopause.
APA, Harvard, Vancouver, ISO, and other styles
9

Beesley, Vanessa Lea. "The experience of gynaecological cancer survivors : supportive care needs and use." Queensland University of Technology, 2006. http://eprints.qut.edu.au/16355/.

Full text
Abstract:
Gynaecological cancer survivorship has been addressed in only a limited body of research. After completion of treatment, women with gynaecological cancer face many challenges. It is pertinent that we understand the wellbeing and morbidity issues of this group of survivors, as well as their supportive care needs and use. With this understanding, it will be possible to better target health care initiatives and services to those gynaecological cancer survivors who require help. Accordingly, the objectives of this study were to determine the prevalence of site-specific morbidities, support being utilised, and unmet needs, as well as to determine the correlates of supportive care needs and use. To address this, a cross-sectional mail survey of 1774 Queensland gynaecological cancer survivors three months to five years post-diagnosis was conducted in 2004 (56.5% response rate, n=802 of 1420 eligible participants). Women were recruited from the Queensland Gynaecological Cancer Registry, which covered approximately 85% of all gynaecological cancer patients in Queensland at the time of this study. The questionnaire measured a range of factors to reflect a social-ecological perspective. This broader perspective was utilised to extend the current understanding which is limited to a biopsychosocial approach. Main outcomes were measured with standardised and validated instruments where possible, including the Supportive Care Needs Survey, Functional Assessment of Cancer Therapy, Duke-UNC Functional Social Support Questionnaire and the Active Australia Survey. The results of this survey showed that while quality of life was high on average (median 91, range 30-108), some women experienced debilitating site-specific conditions. Ten percent reported being diagnosed with lower limb lymphoedema and eight percent of women reported that their gynaecological cancer had made sexual relations too difficult or too uncomfortable. Women accessed multiple sources of support within their communities including a variety of support services (54%) and complementary therapies (29%). Characteristics associated with use of support services include: younger age, being retired, having been diagnosed with a gynaecological cancer other than uterine, having had open bowel resection, having been treated at multiple centres, being in remission, being obese. On average, women reported having excellent social support (median 37, range 8-40). Some women made changes to healthier behaviours following their cancer diagnosis, such as increasing their fruit and vegetable intake (23%) or physical activity levels (10%) or decreasing their alcohol consumption (24%) or cigarette smoking (10%); however, nearly half (44%) of women decreased their physical activity level. A population comparison of health behaviours between gynaecological cancer survivors and Queensland women highlighted the significantly lower level of sufficient physical activity and higher level of obesity in the cancer survivor population, as well as the low levels of adequate vegetable intake in both populations. Forty-three percent of gynaecological cancer survivors reported having at least one moderate or high level unmet supportive care need. In particular, needing help with fear about the cancer spreading, concerns about the worries of those close to them, uncertainty about the future, lack of energy/tiredness, and not being able to do things they used to do, were most important to this group. These leading need items were all within the psychological and physical/daily living supportive care domains. Some unmet sexuality and health system/information needs were also reported. Groups with higher odds of unmet needs included those women who more recently completed treatment, whose disease was still present, who had children still living in the home, who had diagnosed lymphoedema, who experienced treatment-related menopause, who were unable to work due to illness and who lived in rural and remote regions of Queensland. These results indicate that women with gynaecological cancer in Queensland are doing quite well overall; however, there is still room for improvement in a few key areas of public health importance. In line with the social-ecological model, resources need to be targeted at all levels of support including personal, social, health care and broader organisational, community, policy and media levels. In particular, the following recommendations are made: 1. Assistance with the particular reported unmet psychological and physical/daily living needs is a priority. Support services should be tailored to the identified groups of survivors who had higher odds of unmet needs, both in terms of development of written materials that reflect these groups' circumstances and implementation of programs or workshops specific to these groups. In particular, the development of a number of programs or workshops are recommended that discuss the specific psychological and physical/ daily living outcomes of women who a) live with cancer, b) live with children after cancer treatment, c) live with lymphoedema, d) have had treatment-related menopause or e) are unable to work due to illness, and how and where women can get help with managing these. These programs should be implemented by support organisations in the period closely following treatment completion and should consider technologies such as video-conferencing to reach women who are in rural and remote areas. 2. More specific written information for cancer survivors about things they can do to help themselves get well is needed, in lay-person friendly format. This information should address the value of particular dietary items, complementary therapies and types of physical activities that are safe and beneficial to cancer survivors' quality of life. 3. An evidenced-based physical activity intervention, targeting overweight and obese gynaecological cancer survivors is recommended, to reduce the weight issues of this population. 4. To facilitate the triage of cancer survivors to appropriate health care information and other support initiatives, cancer survivors' awareness of the Queensland Cancer Fund needs to be raised substantially. Practitioner education and discharge planning directives are recommended to ensure information about the Queensland Cancer Fund is disseminated. 5. To address the substantially unmet information and physical/ daily living needs specific to lymphoedema sufferers, it is recommended that self-management information and referral information for suppliers and services for lymphoedema management be given to women in high lymphoedema risk groups, as part of the hospital discharge procedure, as well as when symptoms are diagnosed, to ensure a continuum of care is maintained. 6. Clinical practice guidelines for cancer care and, correspondingly, support programs, need to expand from acute care to managing the long-term psychological, physical and sexual health consequences. Several topics for research are likely to be important in the future, including more specific research into why uterine cancer survivors reported higher odds of unmet psychological needs and yet were less likely to use support services, what specific help women with unmet needs would prefer, the effects of lower limb lymphoedema on survivors' quality of life, and why there isn't greater use of existing support services, especially among women with morbidity such as lymphoedema and issues associated with treatment-related menopause.
APA, Harvard, Vancouver, ISO, and other styles
10

Gardner, Robert B. "A Holistic Assessment of the Perceived Supportive Care Needs of Cancer Patients during Treatment." ScholarWorks@UNO, 2008. http://scholarworks.uno.edu/td/823.

Full text
Abstract:
The purpose of the study was to describe the personal experience of individuals undergoing cancer treatment in an outpatient clinic by examining their perceived supportive care needs. The theoretical basis of the study lies in Alfred Adler's holistic view of human beings as unique and indivisible (1927/1954). Six individuals recently diagnosed with cancer were recruited from the same regional outpatient cancer clinic located at a major university medical center. A semi-structured interview process with open-ended questions was utilized to understand how people individually and collectively experience cancer and cancer treatment. The 17 factors of the wellness model (Witmer, Sweeney, & Myers, 1998) were used to assess the perceived supportive care needs of the study's participants. Data were analyzed using Interpretative Phenomenological Analysis (Smith, 1998) to ascertain emergent themes and interpret the meanings of the perceptions patients have of their cancer experience. The data resulted in eight major themes being present including facing mortality; uncertainty about the future; understanding cancer diagnosis and treatment; reliance on faith; maintaining control; love and support from family; physical impact of cancer; and importance of self-care. These themes provide insight into the perceived supportive care needs that patients experience during cancer treatment. With the exception of cultural and gender domains, the holistic assessment process identified patients' needs. The factors of wellness appear to capture the experience of individuals during cancer treatment. As an approach to assessing the coping skills of cancer patients, the wellness model seems appropriate for use by clinical mental health counselors. Implications for counselor theory, training, and practice with this unique client population are discussed.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Supportive medicines in cancer"

1

Cho, William C. S., ed. Supportive Cancer Care with Chinese Medicine. Dordrecht: Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-90-481-3555-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

J, Klastersky, Schimpff Stephen C. 1941-, and Senn Hansjörg, eds. Supportive care in cancer: A handbook for oncologists. 2nd ed. New York: M. Dekker, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Woodruff, Roger. Palliative medicine: Symptomatic and supportive care for patients with advanced cancer and AIDS. 3rd ed. Oxford: Oxford University Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Woodruff, Roger. Palliative medicine: Symptomatic and supportive care for patients with advanced cancer and AIDS. Melbourne: Asperula, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Palliative medicine: Evidence-based symptomatic and supportive care for patients with advanced cancer. 4th ed. Oxford: Oxford University Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Alberts, David, Maria Lluria-Prevatt, Stephanie Kha, and Karen Weihs, eds. Supportive Cancer Care. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-24814-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nair, Raj, ed. Orofacial Supportive Care in Cancer. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-86510-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ettinger, David S., ed. Supportive Care in Cancer Therapy. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-291-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Senn, Hans-Jörg, Agnes Glaus, and Luzius Schmid, eds. Supportive Care in Cancer Patients. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-82932-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sara, Faithfull, and Wells Mary MSc, eds. Supportive care in radiotherapy. New York: Churchill Livingstone, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Supportive medicines in cancer"

1

Wong, Raimond, and Stephen M. Sagar. "Supportive Cancer Care Using Chinese Medicine." In Supportive Cancer Care with Chinese Medicine, 1–37. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3555-4_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cozma, Adrian, Maitry Patel, Edward Chow, and Srinivas Raman. "Cancer: Radiotherapy." In Textbook of Palliative Medicine and Supportive Care, 623–38. 3rd ed. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9780429275524-65.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lin, Jaung-Geng, and Yi-Hung Chen. "Supportive Cancer Care with Acupuncture." In Supportive Cancer Care with Chinese Medicine, 39–54. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3555-4_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lee, Myeong Soo, Kevin W. Chen, and Edzard Ernst. "Supportive Cancer Care with Qigong." In Supportive Cancer Care with Chinese Medicine, 77–94. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3555-4_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sun, Y. "The Role of Traditional Chinese Medicine in Supportive Care of Cancer Patients." In Supportive Care in Cancer Patients, 327–34. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-82932-1_41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zhang, Ruixin, and Lixing Lao. "Modern Cancer Research on Chinese Medicine: Acupuncture." In Supportive Cancer Care with Chinese Medicine, 253–70. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3555-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bao, Ting, Lixing Lao, and Aditya Bardia. "Cancer Pain Control with Traditional Chinese Medicine." In Supportive Cancer Care with Chinese Medicine, 169–225. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3555-4_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ernst, Edzard. "Palliative and Supportive Care." In So-Called Alternative Medicine (SCAM) for Cancer, 127–89. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-74158-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ventafridda, V. "Palliative Care: A New Reality in Medicine." In Supportive Care in Cancer Patients II, 393–98. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-84138-5_46.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dorsher, Peter, and Zengfu Peng. "Chinese Medicinal Herbs Use in Managing Cancer." In Supportive Cancer Care with Chinese Medicine, 55–75. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-3555-4_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Supportive medicines in cancer"

1

Elkefi, Safa, Onur Asan, and Tina W F Yen. "Using Human factors approach to evaluate patient-centered cancer care." In 13th International Conference on Applied Human Factors and Ergonomics (AHFE 2022). AHFE International, 2022. http://dx.doi.org/10.54941/ahfe1002186.

Full text
Abstract:
Patient-centered care (PCC) approaches are critical for the delivery of high-quality care in cancer care where the therapeutic alliance between patients and the oncologists is frequent over extended periods of time. The concept of patient-centered care has received increased attention since the publication of the 2001 Institute of Medicine (IOM) report Crossing the Quality Chasm. In this study, we create and evaluate a new framework for patient-centered care in cancer using human factors approaches. Many initiatives focused on developing technologies that help foster PCC by increasing patients’ access to information and facilitating self-monitoring and patient convenience. This paper makes an important contribution to the literature by historically examining the evolution of the definitions of care approaches from disease-centered care focusing on curing the diseases to patient-centered care satisfying patients’ needs to person-centered care. Instead of treating people like victims of diseases, this model recognizes their need for more than one professional to support them emphasizing their capabilities and potential to improve their own health by themselves. It also provides a different and complementary way to the visit-oriented approach furnishing more accessible and continuous care over time, Our contribution also covers summarizing the existing measures adopted to measure its components and finally suggests a socio-technical framework based on the human factors approach to measuring PCC effectiveness. Our approach to measuring PCC is grounded in the conceptual framework we are suggesting that evaluates the effectiveness of patient-centered care based on a socio-technical perspective. We link the cognitive perception of patients towards PCC (Cognitive Sensory Input) to their exposure to external factors (Exposure) that may affect their (Cognition) behavior. A holistic approach recognizing health care as a dynamic socio-technical system in which sub-elements interact with each other remains necessary to better understand the system and its constraints in cancer care. We use a case study to emphasize the importance and need of such a human factors-based framework in providing a better quality of care and improving health outcomes. Achieving high-quality care is a complex pursuit in any setting especially for cancer care and improving the patient journey requires an integrated system of care and productive interactions among many system levels. By understanding the work system components, the design and integration of tasks, technology, and clinical processes can be reviewed to better support the respective needs of individuals while optimizing system performance. A supportive work environment and a highly engaged workforce are highly correlated with improved quality of patient-centered care and hospital performance. At the population level, case managers, navigators, quality officers, and administrators may track outcomes across patients.This framework can help organize clinical interventions that aim to control cancer patients’ behavior from a patient-centered perspective. It can also help technology designers by giving them insight into how patient-centeredness in the design of health informatics can impact cancer patients’ behavior. In addition, patient-centered designs can enhance technology acceptance among cancer patients making it easier to adopt technology for follow-up reasons by involving human factors and ergonomics principles in order to ensure successful results.
APA, Harvard, Vancouver, ISO, and other styles
2

Filyaev, M. A., and E. E. Akubova. "МЕТОДОЛОГИЯ ШКОЛЫ «PSY2.0» ПРИ КУРАЦИИ ПАЦИЕТОВ С ОНКОЛОГИЧЕСКИМИ ЗАБОЛЕВАНИЯМИ." In ПЕРВЫЙ МЕЖКОНТИНЕНТАЛЬНЫЙ ЭКСТЕРРИТОРИАЛЬНЫЙ КОНГРЕСС «ПЛАНЕТА ПСИХОТЕРАПИИ 2022: ДЕТИ. СЕМЬЯ. ОБЩЕСТВО. БУДУЩЕЕ». Crossref, 2022. http://dx.doi.org/10.54775/ppl.2022.78.75.001.

Full text
Abstract:
Onco-psychosomatics is at the junction of sciences: psychophysiology, biology, medicine, psychology, psychosomatics and oncology. In recent years this field has developed intensively, and we are witnessing the transition from supportive counseling to a new integral paradigm of patient support. The PSY2.0 methodology extends the technology of psychological work with a cancer patient and sets new standards of working with them. The basic principles consist in a complex approach in the consideration of the whole human being, understanding of the biological laws of the functioning of the body, the relationship between mental processes and the biological meanings of organs and implies work with the psychogenic factor that led to the disease. Successful application of the PSY 2.0 methodology in various areas of counseling is achieved by combining psychological impact and changes in bodily response, including at the level of organic changes in a person. The report highlights the practical experience of cancer patients' treatment and successful use of the PSY 2.0 method, modern hypnotherapy methods, provocative therapy and regressive hypnosis in clinical practice. Онкопсихосоматика находится на стыке наук: психофизиологии, биологии, медицины, психологии, психосоматики и онкологии. За последние годы это направление интенсивно развивается, и мы наблюдаем переход из поддерживающей консультативной помощи в новую интегральную парадигму сопровождения пациента. Методика PSY2.0 расширяет технологию психологической работы с пациентом с «онко» диагнозом и задает новые стандарты работы с ними. Основные принципы заключаются в комплексном подходе в восприятии человека, понимание биологических законов функционирования организма, взаимосвязи между психическими процессами и биологическими смыслами органов и подразумевает работу с психогенным фактором, который привел к заболеванию. Успешное применение в различных сферах консультирования методики PSY 2.0 достигается совмещением психологического воздействия и перемен в телесном реагировании, в том числе на уровне органических изменений в человеке. Доклад освещает практический опыт курации онкологических больных и успешное использование метода PSY 2.0, методов современной гипнотерапии, провокативной терапии, регрессивного гипноза в клинической практике.
APA, Harvard, Vancouver, ISO, and other styles
3

Bowers, Ben, Kristian Pollock, Sam Barclay, and Stephen Barclay. "22 General practitioners’ decisions about prescribing anticipatory medicines at the end of life: a qualitative study." In The APM’s Supportive & Palliative Care Conference, Accepted Oral and Poster Abstract Submissions, The Harrogate Convention Centre, Harrogate, England, 21–22 March 2019. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/bmjspcare-2019-asp.21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Valery, Patricia C., Vanessa L. Beesley, Catherine Jacka, Monika Janda, Lisa Whop, Peter O'Rourke, Adele Green, and Gail Garvey. "Abstract B4: Supportive care needs survey for Australian indigenous cancer patients." In Abstracts: AACR International Conference on the Science of Cancer Health Disparities‐‐ Sep 30-Oct 3, 2010; Miami, FL. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1055-9965.disp-10-b4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shore, Kelsey, Kathryn E. Weaver, Karen M. Winkfield, Janet A. Tooze, Carla Strom, and Jimmy Ruiz. "Abstract D046: Supportive care needs in diverse cancer patients treated at a Comprehensive Cancer Center." In Abstracts: Twelfth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 20-23, 2019; San Francisco, CA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7755.disp19-d046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gancheva, Veska. "A big data management approach for computer aided breast cancer diagnostic system supporting precision medicine." In PROCEEDINGS OF THE 45TH INTERNATIONAL CONFERENCE ON APPLICATION OF MATHEMATICS IN ENGINEERING AND ECONOMICS (AMEE’19). AIP Publishing, 2019. http://dx.doi.org/10.1063/1.5133589.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Davis, Claudia M. "Abstract C01: Understanding supportive care factors among African American breast cancer survivors." In Abstracts: Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; September 25-28, 2016; Fort Lauderdale, FL. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7755.disp16-c01.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhang, Xufei, Hao Li, Herschel Angela Espiritu, Anita Kim, and Li Zhong. "Abstract 4551: Emerging effects of Chinese herbal medicines on human cancer cells proliferation." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kerr, Sarah, Mary Mambwere, and Georgia Hardavella. "Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lou, Shan, Alexandria Fink, Jay Wang, Jesse Turner, Monica Thanawala, Garmen Yuen, Alexandra Lantermann, et al. "Abstract LB-B17: Uncovering novel cancer therapeutics using the Exoneural Medicines Platform: The role of innervation in cancer." In Abstracts: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; October 26-30, 2019; Boston, MA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1535-7163.targ-19-lb-b17.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Supportive medicines in cancer"

1

Cohen, Isaac, and Jane N. Winter. Ex vivo Expanded Megakaryocytes for Supportive Care of Breast Cancer Patients. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada400103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Whybrow-Huppatz, Isabel, Rachael Walker, Jasjot Maggo, Dianne Murphy, and Suetonia Palmer. Cannabis medicines for symptom management in adults with chronic non-cancer conditions. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0090.

Full text
Abstract:
Review question / Objective: To estimate the benefits and harms of cannabis medicines to manage symptoms in adults with chronic non-cancer conditions. We will conduct a systematic review with meta-analysis of randomised controlled trials. Condition being studied: Chronic non-cancer conditions. Information sources: We will search the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE accessed via Ovid (from 1966), EMBASE accessed via Ovid (from 1980), PschINFO accessed via Ovid (from inception) and LILACS (from inception). Appendix 1 shows the search strategy for Ovid MEDLINE.
APA, Harvard, Vancouver, ISO, and other styles
3

Jiang, Huizhong, Yali Jiang, Dan Yu, Fengxi Long, Li Luo, Zhu Yang, and Dongxin Tang. Meta-Analysis of Capecitabine-Based Chemotherapy Combined With Traditional Chinese Medicines for Colorectal Cancer Treatment. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lipkus, Isaac. The Effects of Supportive and Nonsupportive Behaviors on the Quality of Life of Prostate Cancer Patients and Their Spouses. Fort Belvoir, VA: Defense Technical Information Center, February 2002. http://dx.doi.org/10.21236/ada410543.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lines, Lisa M., Florence K. L. Tangka, Sonja Hoover, and Sujha Subramanian. People with Colorectal Cancer in SEER-Medicare: Part D Uptake, Costs, and Outcomes. RTI Press, May 2020. http://dx.doi.org/10.3768/rtipress.2020.rr.0037.2005.

Full text
Abstract:
Limited information exists about enrollment in Part D prescription coverage by Medicare beneficiaries with cancer. Part D coverage may increase access to medicines. This study evaluated patterns of Part D uptake and costs and assessed the effects of coverage on hospitalizations and emergency department (ED) use among people with colorectal cancer (CRC). We analyzed Surveillance, Epidemiology, and End Results (SEER)–Medicare linked data on fee-for-service (FFS) Medicare beneficiaries with at least 36 months of follow-up who were diagnosed with CRC at any point from January 2007 through December 2010, and a matched cohort of beneficiaries without cancer. Dual (Medicare/Medicaid) enrollees were excluded because they are automatically enrolled in Part D. Among beneficiaries with CRC (n=12,774), 39 percent had complete Part D coverage, defined as coverage in the diagnosis year and 2 subsequent years; the rate was 38 percent in the matched comparison cohort (P=.119). Among those with complete Part D coverage, there was no significant difference in annual prescription drug costs between people with CRC ($3,157, 95% confidence interval [CI]: $3,098–$3,216) and without ($3,113, 95% CI: $3,054–$3,172). Among people with CRC, odds of ED use ranged from unchanged to marginally higher for those with no or partial Part D coverage, (adjusted odds ratio: 1.09, 95% CI: 1.00–1.18), compared with those with complete Part D coverage. Lack of continuous Part D coverage was associated with more ED use among Medicare FFS beneficiaries with CRC in 2007–2013. Among people with Part D coverage, prescription drug costs varied little between those with CRC and matched beneficiaries without cancer.
APA, Harvard, Vancouver, ISO, and other styles
6

Ly, Lena, Jennifer Philip, Peter Hudson, and Natasha Smallwood. Singing for people with advance chronic respiratory diseases: a qualitative meta-synthesis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0017.

Full text
Abstract:
Review question / Objective: This study undertook a meta-synthesis of qualitative data with the aim of collating, synthesizing, and evaluating the current evidence regarding the experiences of singing for people with advanced chronic respiratory disease. Condition being studied: Advanced respiratory illnesses are disorders that impact the airways and other structures of the lung. People with lung cancer, chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) frequently experience progressive, frightening breathlessness, cough and fatigue, which affect their quality of life. Furthermore, people with advanced chronic respiratory disease (CRD) and their carers experience a high prevalence of loneliness and uncertainty, especially if breathlessness is felt to herald death and thus, require both psychological and practical supportive care to cope with their symptoms.
APA, Harvard, Vancouver, ISO, and other styles
7

McEntee, Alice, Sonia Hines, Joshua Trigg, Kate Fairweather, Ashleigh Guillaumier, Jane Fischer, Billie Bonevski, James A. Smith, Carlene Wilson, and Jacqueline Bowden. Tobacco cessation in CALD communities. The Sax Institute, June 2022. http://dx.doi.org/10.57022/sneg4189.

Full text
Abstract:
Background Australia is a multi-cultural society with increasing rates of people from culturally and linguistically diverse (CALD) backgrounds. On average, CALD groups have higher rates of tobacco use, lower participation in cancer screening programs, and poorer health outcomes than the general Australian population. Lower cancer screening and smoking cessation rates are due to differing cultural norms, health-related attitudes, and beliefs, and language barriers. Interventions can help address these potential barriers and increase tobacco cessation and cancer screening rates among CALD groups. Cancer Council NSW (CCNSW) aims to reduce the impact of cancer and improve cancer outcomes for priority populations including CALD communities. In line with this objective, CCNSW commissioned this rapid review of interventions implemented in Australia and comparable countries. Review questions This review aimed to address the following specific questions: Question 1 (Q1): What smoking cessation interventions have been proven effective in reducing or preventing smoking among culturally and linguistically diverse communities? Question 2 (Q2): What screening interventions have proven effective in increasing participation in population cancer screening programs among culturally and linguistically diverse populations? This review focused on Chinese-, Vietnamese- and Arabic-speaking people as they are the largest CALD groups in Australia and have high rates of tobacco use and poor screening adherence in NSW. Summary of methods An extensive search of peer-reviewed and grey literature published between January 2013-March 2022 identified 19 eligible studies for inclusion in the Q1 review and 49 studies for the Q2 review. The National Health and Medical Research Council (NHMRC) Levels of Evidence and Joanna Briggs Institute’s (JBI) Critical Appraisal Tools were used to assess the robustness and quality of the included studies, respectively. Key findings Findings are reported by components of an intervention overall and for each CALD group. By understanding the effectiveness of individual components, results will demonstrate key building blocks of an effective intervention. Question 1: What smoking cessation interventions have been proven effective in reducing or preventing smoking among culturally and linguistically diverse communities? Thirteen of the 19 studies were Level IV (L4) evidence, four were Level III (L3), one was Level II (L2), none were L1 (highest level of evidence) and one study’s evidence level was unable to be determined. The quality of included studies varied. Fifteen tobacco cessation intervention components were included, with most interventions involving at least three components (range 2-6). Written information (14 studies), and education sessions (10 studies) were the most common components included in an intervention. Eight of the 15 intervention components explored had promising evidence for use with Chinese-speaking participants (written information, education sessions, visual information, counselling, involving a family member or friend, nicotine replacement therapy, branded merchandise, and mobile messaging). Another two components (media campaign and telephone follow-up) had evidence aggregated across CALD groups (i.e., results for Chinese-speaking participants were combined with other CALD group(s)). No intervention component was deemed of sufficient evidence for use with Vietnamese-speaking participants and four intervention components had aggregated evidence (written information, education sessions, counselling, nicotine replacement therapy). Counselling was the only intervention component to have promising evidence for use with Arabic-speaking participants and one had mixed evidence (written information). Question 2: What screening interventions have proven effective in increasing participation in population cancer screening programs among culturally and linguistically diverse populations? Two of the 49 studies were Level I (L1) evidence, 13 L2, seven L3, 25 L4 and two studies’ level of evidence was unable to be determined. Eighteen intervention components were assessed with most interventions involving 3-4 components (range 1-6). Education sessions (32 studies), written information (23 studies) and patient navigation (10 studies) were the most common components. Seven of the 18 cancer screening intervention components had promising evidence to support their use with Vietnamese-speaking participants (education sessions, written information, patient navigation, visual information, peer/community health worker, counselling, and peer experience). The component, opportunity to be screened (e.g. mailed or handed a bowel screening test), had aggregated evidence regarding its use with Vietnamese-speaking participants. Seven intervention components (education session, written information, visual information, peer/community health worker, opportunity to be screened, counselling, and branded merchandise) also had promising evidence to support their use with Chinese-speaking participants whilst two components had mixed (patient navigation) or aggregated (media campaign) evidence. One intervention component for use with Arabic-speaking participants had promising evidence to support its use (opportunity to be screened) and eight intervention components had mixed or aggregated support (education sessions, written information, patient navigation, visual information, peer/community health worker, peer experience, media campaign, and anatomical models). Gaps in the evidence There were four noteworthy gaps in the evidence: 1. No systematic review was captured for Q1, and only two studies were randomised controlled trials. Much of the evidence is therefore based on lower level study designs, with risk of bias. 2. Many studies provided inadequate detail regarding their intervention design which impacts both the quality appraisal and how mixed finding results can be interpreted. 3. Several intervention components were found to have supportive evidence available only at the aggregate level. Further research is warranted to determine the interventions effectiveness with the individual CALD participant group only. 4. The evidence regarding the effectiveness of certain intervention components were either unknown (no studies) or insufficient (only one study) across CALD groups. This was the predominately the case for Arabic-speaking participants for both Q1 and Q2, and for Vietnamese-speaking participants for Q1. Further research is therefore warranted. Applicability Most of the intervention components included in this review are applicable for use in the Australian context, and NSW specifically. However, intervention components assessed as having insufficient, mixed, or no evidence require further research. Cancer screening and tobacco cessation interventions targeting Chinese-speaking participants were more common and therefore showed more evidence of effectiveness for the intervention components explored. There was support for cancer screening intervention components targeting Vietnamese-speaking participants but not for tobacco cessation interventions. There were few interventions implemented for Arabic-speaking participants that addressed tobacco cessation and screening adherence. Much of the evidence for Vietnamese and Arabic-speaking participants was further limited by studies co-recruiting multiple CALD groups and reporting aggregate results. Conclusion There is sound evidence for use of a range of intervention components to address tobacco cessation and cancer screening adherence among Chinese-speaking populations, and cancer screening adherence among Vietnamese-speaking populations. Evidence is lacking regarding the effectiveness of tobacco cessation interventions with Vietnamese- and Arabic-speaking participants, and cancer screening interventions for Arabic-speaking participants. More research is required to determine whether components considered effective for use in one CALD group are applicable to other CALD populations.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Supportive medicines in cancer' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography